Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty

a consensus recommendation

Girish P. Joshi, Fred D. Cushner, John W. Barrington, Adolph V. Lombardi, William J. Long, Bryan D. Springer, Bernard N. Stulberg

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Periarticular infiltration analgesia when used as a component of multimodal analgesia regimen has been shown to provide excellent pain relief after major joint replacement surgery. Recently, a liposomal formulation of bupivacaine (Exparel) has been approved for administration into the surgical site to produce postsurgical analgesia. It is a sustained release preparation of bupivacaine that has been shown to provide pain relief for up to 72 hours with a single local administration. Because the success of infiltration technique depends on systematic, extensive, meticulous tissue injection before surgical wound closure, a group convened to address the best practice for periarticular injection techniques for hip and knee replacement surgery. This article provides recommendations for optimal solution for injection (i.e., drug combinations or ``cocktail'' and total volume) as well as detailed description (including illustrations) of the infiltration technique for primary, revision, and unicompartmental knee arthroplasty and primary and revision hip arthroplasty using various surgical approaches.

Original languageEnglish (US)
Pages (from-to)27-35
Number of pages9
JournalJournal of surgical orthopaedic advances
Volume24
Issue number1
StatePublished - Mar 1 2015

Fingerprint

Knee Replacement Arthroplasties
Bupivacaine
Pain Management
Analgesia
Hip
Consensus
Injections
Replacement Arthroplasties
Delayed-Action Preparations
Pain
Drug Combinations
Practice Guidelines
Arthroplasty
Knee

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty : a consensus recommendation. / Joshi, Girish P.; Cushner, Fred D.; Barrington, John W.; Lombardi, Adolph V.; Long, William J.; Springer, Bryan D.; Stulberg, Bernard N.

In: Journal of surgical orthopaedic advances, Vol. 24, No. 1, 01.03.2015, p. 27-35.

Research output: Contribution to journalArticle

Joshi, Girish P. ; Cushner, Fred D. ; Barrington, John W. ; Lombardi, Adolph V. ; Long, William J. ; Springer, Bryan D. ; Stulberg, Bernard N. / Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty : a consensus recommendation. In: Journal of surgical orthopaedic advances. 2015 ; Vol. 24, No. 1. pp. 27-35.
@article{8eadf4d97b1342fa8de9e4f99916307f,
title = "Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty: a consensus recommendation",
abstract = "Periarticular infiltration analgesia when used as a component of multimodal analgesia regimen has been shown to provide excellent pain relief after major joint replacement surgery. Recently, a liposomal formulation of bupivacaine (Exparel) has been approved for administration into the surgical site to produce postsurgical analgesia. It is a sustained release preparation of bupivacaine that has been shown to provide pain relief for up to 72 hours with a single local administration. Because the success of infiltration technique depends on systematic, extensive, meticulous tissue injection before surgical wound closure, a group convened to address the best practice for periarticular injection techniques for hip and knee replacement surgery. This article provides recommendations for optimal solution for injection (i.e., drug combinations or ``cocktail'' and total volume) as well as detailed description (including illustrations) of the infiltration technique for primary, revision, and unicompartmental knee arthroplasty and primary and revision hip arthroplasty using various surgical approaches.",
author = "Joshi, {Girish P.} and Cushner, {Fred D.} and Barrington, {John W.} and Lombardi, {Adolph V.} and Long, {William J.} and Springer, {Bryan D.} and Stulberg, {Bernard N.}",
year = "2015",
month = "3",
day = "1",
language = "English (US)",
volume = "24",
pages = "27--35",
journal = "Journal of the Southern Orthopaedic Association",
issn = "1548-825X",
publisher = "Data Trace Publishing Co.",
number = "1",

}

TY - JOUR

T1 - Techniques for periarticular infiltration with liposomal bupivacaine for the management of pain after hip and knee arthroplasty

T2 - a consensus recommendation

AU - Joshi, Girish P.

AU - Cushner, Fred D.

AU - Barrington, John W.

AU - Lombardi, Adolph V.

AU - Long, William J.

AU - Springer, Bryan D.

AU - Stulberg, Bernard N.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Periarticular infiltration analgesia when used as a component of multimodal analgesia regimen has been shown to provide excellent pain relief after major joint replacement surgery. Recently, a liposomal formulation of bupivacaine (Exparel) has been approved for administration into the surgical site to produce postsurgical analgesia. It is a sustained release preparation of bupivacaine that has been shown to provide pain relief for up to 72 hours with a single local administration. Because the success of infiltration technique depends on systematic, extensive, meticulous tissue injection before surgical wound closure, a group convened to address the best practice for periarticular injection techniques for hip and knee replacement surgery. This article provides recommendations for optimal solution for injection (i.e., drug combinations or ``cocktail'' and total volume) as well as detailed description (including illustrations) of the infiltration technique for primary, revision, and unicompartmental knee arthroplasty and primary and revision hip arthroplasty using various surgical approaches.

AB - Periarticular infiltration analgesia when used as a component of multimodal analgesia regimen has been shown to provide excellent pain relief after major joint replacement surgery. Recently, a liposomal formulation of bupivacaine (Exparel) has been approved for administration into the surgical site to produce postsurgical analgesia. It is a sustained release preparation of bupivacaine that has been shown to provide pain relief for up to 72 hours with a single local administration. Because the success of infiltration technique depends on systematic, extensive, meticulous tissue injection before surgical wound closure, a group convened to address the best practice for periarticular injection techniques for hip and knee replacement surgery. This article provides recommendations for optimal solution for injection (i.e., drug combinations or ``cocktail'' and total volume) as well as detailed description (including illustrations) of the infiltration technique for primary, revision, and unicompartmental knee arthroplasty and primary and revision hip arthroplasty using various surgical approaches.

UR - http://www.scopus.com/inward/record.url?scp=84936083876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936083876&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 27

EP - 35

JO - Journal of the Southern Orthopaedic Association

JF - Journal of the Southern Orthopaedic Association

SN - 1548-825X

IS - 1

ER -